In the latest close session, Albemarle (ALB) was down 2.84% at $95.39. The stock's change was less than the S&P 500's daily loss of 1.09%. Elsewhere, the Dow saw a downswing of 0.34%, while the tech-heavy Nasdaq depreciated by 2.15%.
Heading into today, shares of the specialty chemicals company had lost 14.66% over the past month, lagging the Basic Materials sector's loss of 4.63% and the S&P 500's gain of 2.44%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 4, 2026. The company is expected to report EPS of $2.44, up 1384.21% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.49 billion, up 14.15% from the year-ago period.
ALB's full-year Zacks Consensus Estimates are calling for earnings of $11.3 per share and revenue of $6.09 billion. These results would represent year-over-year changes of +1530.38% and +18.41%, respectively.
Investors might also notice recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.83% lower. Albemarle presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Albemarle is presently trading at a Forward P/E ratio of 8.69. This expresses a discount compared to the average Forward P/E of 15.28 of its industry.
Also, we should mention that ALB has a PEG ratio of 0.58. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified industry had an average PEG ratio of 1.2 as trading concluded yesterday.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 183, putting it in the bottom 26% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Albemarle Corporation (ALB): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).